Westlake Village BioPartners
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$1.4B
Focus Areas
7
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Annexon | $761.7M |
| Kyverna Therapeutics | $473.3M |
| Sagimet Biosciences | $157.1M |